Streetbeat News

Products Services

PTCT

PTC Therapeutics shared promising interim data from the 12-week portion of the PIVOT-HD Phase 2 study of PTC518 in Huntington's disease patients. The study showed dose-dependent lowering of Huntingtin protein levels and PTC518 treatment was well tolerated with no serious adverse events.

Portfolio Pulse from Vandana Singh

June 21, 2023 | 6:24 pm

TAK

TEVA

The supply of ADHD medications, including Vyvanse and Adderall, is dwindling in the US due to manufacturing complications and labor shortages at Teva Pharmaceutical Industries and Takeda Pharmaceutical. The shortage has reached a five-year high, with Vyvanse prescriptions surging in 2023.

Portfolio Pulse from Vandana Singh

June 21, 2023 | 6:23 pm

SILO

Silo Pharma (NASDAQ:SILO) has been granted a new patent by the U.S. Patent and Trademark Office for its peptide-targeted liposomal delivery method for the treatment, diagnosis, and imaging of diseases and disorders. The patent covers the company's SPU-21 anti-arthritis drug, which has shown potential in inhibiting arthritic progression in preclinical animal models.

Portfolio Pulse from Jelena Martinovic

June 21, 2023 | 6:21 pm

BLK

F

GM

RIVN

TSLA

Tesla's stock price increased significantly after news broke that Ford, General Motors, and Rivian will use Tesla's charging network, adding $50B to Tesla's market capitalization. Investors are questioning if any analysis was done before risking their money. Meanwhile, BlackRock filed for a Bitcoin ETF, causing enthusiasm in the cryptocurrency.

Portfolio Pulse from The Arora Report

June 21, 2023 | 6:09 pm

GNRC

ERCOT, the Electric Reliability Council of Texas, has asked customers to voluntarily cut back on energy consumption due to a heat wave causing high temperatures throughout the state. Texas' unique power grid can face restraints and outages during extreme weather conditions. Generac Holdings Inc (NYSE:GNRC), a manufacturer of generators, could benefit from the uncertainty in Texas.

Portfolio Pulse from Aaron Bry

June 21, 2023 | 5:28 pm

LLY

The U.S. FDA has approved Jardiance (empagliflozin) for the treatment of type 2 diabetes in children aged 10 and older. Jardiance, developed by Boehringer Ingelheim and Eli Lilly and Company (NYSE:LLY), is the first and only SGLT2 inhibitor approved for this patient population.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 5:16 pm

RKLB

Space Flight Laboratory (SFL) has completed the Telesat LEO 3 demonstration microsatellite and shipped it to Rocket Lab Launch Complex 1 in New Zealand. The launch is scheduled for no earlier than Q3 2023. Telesat is a major satellite operator, and SFL has a 25-year heritage with 65 operational successes.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 5:09 pm

NKE

Nike and Fortnite, Epic Games' online battle royale, have launched a collaboration called Airphoria, merging the physical and digital worlds. The collaboration features Nike's Air Max line and includes exclusive in-game items. Nike has also released a limited Airphoria collection available for purchase on its website.

Portfolio Pulse from Franca Quarneti

June 21, 2023 | 5:09 pm

MSFT

Microsoft is raising the prices of its Xbox Series X consoles in most countries and increasing the monthly prices of its Xbox Game Pass and Xbox Game Pass Ultimate subscriptions starting next month. The price hikes are intended to match local market conditions and are not related to the proposed acquisition of Activision Blizzard.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 5:04 pm

ARBK

BTBT

MSTR

Crypto-related stocks MicroStrategy, Bit Digital, and Argo Blockchain are moving higher due to gains in the crypto market, led by Bitcoin and Ethereum. The market is benefiting from positive developments such as the launch of EDX Markets exchange, backed by Charles Schwab, Fidelity, and Citadel Securities, and BlackRock's application for a spot Bitcoin ETF.

Portfolio Pulse from Erica Kollmann

June 21, 2023 | 4:54 pm